[go: up one dir, main page]

NO20071754L - Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav - Google Patents

Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav

Info

Publication number
NO20071754L
NO20071754L NO20071754A NO20071754A NO20071754L NO 20071754 L NO20071754 L NO 20071754L NO 20071754 A NO20071754 A NO 20071754A NO 20071754 A NO20071754 A NO 20071754A NO 20071754 L NO20071754 L NO 20071754L
Authority
NO
Norway
Prior art keywords
preparation
biotinylated hexadecasaccharides
hexadecasaccharides
biotinylated
oso
Prior art date
Application number
NO20071754A
Other languages
English (en)
Inventor
Maurice Petitou
Jean-Marc Herbert
Philippe Duchaussoy
Pierre Savi
Jean Pascal Herault
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071754(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20071754L publication Critical patent/NO20071754L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

Biotinylerte heksadekasakkarider, anvendelse som medisiner Det er beskrevet nye biotinylerte heksadekasakkarider av generell formel (I), hvori: Biot er et biotinderivat; R, Ri og R2 betyr uavhengig av hverandre en Ci^ alkoksy eller en -OSO3"; R3 betyr en Cm alkoksy eller en -OSO3" eller R3 utgjør en -0-CH2-bro; Pe betyr en sakkaiidsekvens; så vel som deies farmasøytisk akseptable salter, og deres anvendelse som medisiner.
NO20071754A 2004-09-09 2007-04-02 Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav NO20071754L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
NO20071754L true NO20071754L (no) 2007-04-02

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071754A NO20071754L (no) 2004-09-09 2007-04-02 Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav

Country Status (39)

Country Link
US (3) US20070270342A1 (no)
EP (1) EP1791872B1 (no)
JP (1) JP5108519B2 (no)
KR (1) KR101223364B1 (no)
CN (1) CN101039963B (no)
AR (1) AR051286A1 (no)
AT (1) ATE420118T1 (no)
AU (1) AU2005284080B2 (no)
BR (1) BRPI0515078A (no)
CA (1) CA2577258C (no)
CY (1) CY1109126T1 (no)
DE (1) DE602005012287D1 (no)
DK (1) DK1791872T3 (no)
EA (1) EA012587B1 (no)
EC (1) ECSP077272A (no)
ES (1) ES2320576T3 (no)
FR (1) FR2874924B1 (no)
GT (1) GT200500250A (no)
HK (1) HK1113686A1 (no)
HN (1) HN2005000518A (no)
HR (1) HRP20090180T1 (no)
IL (1) IL181569A (no)
MA (1) MA28859B1 (no)
MX (1) MX2007002875A (no)
MY (1) MY140666A (no)
NI (1) NI200700063A (no)
NO (1) NO20071754L (no)
PA (1) PA8644201A1 (no)
PE (1) PE20060663A1 (no)
PL (1) PL1791872T3 (no)
PT (1) PT1791872E (no)
RS (1) RS50762B (no)
SI (1) SI1791872T1 (no)
SV (1) SV2006002221A (no)
TN (1) TNSN07053A1 (no)
TW (1) TW200612970A (no)
UY (1) UY29102A1 (no)
WO (1) WO2006030104A1 (no)
ZA (1) ZA200702255B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
TW200612970A (en) 2006-05-01
ES2320576T3 (es) 2009-05-25
DK1791872T3 (da) 2009-05-04
CA2577258A1 (fr) 2006-03-23
US8703738B2 (en) 2014-04-22
EP1791872A1 (fr) 2007-06-06
IL181569A0 (en) 2007-07-04
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
CN101039963B (zh) 2011-07-27
EP1791872B1 (fr) 2009-01-07
AR051286A1 (es) 2007-01-03
MY140666A (en) 2010-01-15
CN101039963A (zh) 2007-09-19
KR101223364B1 (ko) 2013-01-16
ECSP077272A (es) 2007-03-29
ATE420118T1 (de) 2009-01-15
PL1791872T3 (pl) 2009-06-30
HRP20090180T1 (en) 2009-05-31
SV2006002221A (es) 2006-01-13
WO2006030104A1 (fr) 2006-03-23
HK1113686A1 (en) 2008-10-10
PA8644201A1 (es) 2006-05-16
JP2008512538A (ja) 2008-04-24
SI1791872T1 (sl) 2009-06-30
EA012587B1 (ru) 2009-10-30
AU2005284080A1 (en) 2006-03-23
CA2577258C (fr) 2013-05-21
KR20070051887A (ko) 2007-05-18
CY1109126T1 (el) 2014-07-02
NI200700063A (es) 2008-03-07
UY29102A1 (es) 2006-04-28
FR2874924B1 (fr) 2006-12-01
JP5108519B2 (ja) 2012-12-26
MX2007002875A (es) 2007-05-16
IL181569A (en) 2011-08-31
US20070270342A1 (en) 2007-11-22
US8557968B2 (en) 2013-10-15
US20130004551A1 (en) 2013-01-03
GT200500250A (es) 2006-04-10
AU2005284080B2 (en) 2011-10-13
US20100279960A1 (en) 2010-11-04
TNSN07053A1 (fr) 2008-06-02
MA28859B1 (fr) 2007-09-03
PT1791872E (pt) 2009-03-27
EA200700594A1 (ru) 2007-08-31
HN2005000518A (es) 2009-06-01
BRPI0515078A (pt) 2008-07-01
PE20060663A1 (es) 2006-08-21
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10

Similar Documents

Publication Publication Date Title
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20071754L (no) Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav
NO20064077L (no) Kemokinreseptorantagonister
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
ATE428422T1 (de) Piperidin-derivate als ccr3-antagonisten
WO2008111441A1 (ja) 医薬組成物
NO20065904L (no) Terapeutiske forbindelser
NO20062370L (no) Amidderivater
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
NO20092033L (no) Nye forbindelser
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20044826L (no) Pyrrolidinderivater
NO20065878L (no) Terapeutiske forbindelser
NO20063597L (no) Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20062150L (no) Nye ketooksadiazolderivater som katepsinhibitorer
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
EP1642880A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
NO20085087L (no) Nye heterocykliske forbindelser
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20051263L (no) Ny anvendelse av benzotiazolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application